Edition:
United States

Sarepta Therapeutics Inc (AB3A.F)

AB3A.F on Frankfurt Stock Exchange

47.27EUR
22 Nov 2017
Change (% chg)

€-0.32 (-0.67%)
Prev Close
€47.59
Open
€47.27
Day's High
€47.27
Day's Low
€47.27
Volume
0
Avg. Vol
151
52-wk High
€47.87
52-wk Low
€25.00

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.32 December 23 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 6 6 6 6
(2) OUTPERFORM 11 11 9 8
(3) HOLD 1 1 2 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.72 1.72 1.76 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 15 55.83 62.00 39.30 64.62
Quarter Ending Mar-18 9 64.84 72.00 59.41 --
Year Ending Dec-17 16 154.03 159.30 147.90 215.13
Year Ending Dec-18 16 312.30 368.50 267.00 346.12
Earnings (per share)
Quarter Ending Dec-17 13 -0.32 -0.10 -0.56 -0.28
Quarter Ending Mar-18 10 -0.27 -0.11 -0.43 --
Year Ending Dec-17 12 -0.73 -0.20 -0.96 -1.46
Year Ending Dec-18 15 -0.57 0.62 -1.74 -0.29

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 40.77 45.95 5.18 12.71
Quarter Ending Jun-17 22.38 35.01 12.64 56.47
Quarter Ending Mar-17 14.25 16.34 2.09 14.67
Quarter Ending Dec-16 4.72 5.42 0.70 14.82
Quarter Ending Sep-16 1.06 0.00 1.06 100.00
Earnings (per share)
Quarter Ending Sep-17 -0.85 -0.76 0.09 -10.38
Quarter Ending Jun-17 -0.91 -0.46 0.45 -49.37
Quarter Ending Mar-17 -0.27 -0.71 0.44 -166.52
Quarter Ending Dec-16 -1.33 -0.87 0.46 -34.39
Quarter Ending Sep-16 -1.32 -1.18 0.14 -10.29

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 55.83 55.83 45.75 45.83 64.62
Quarter Ending Mar-18 64.84 62.85 55.40 57.20 --
Year Ending Dec-17 154.03 154.03 138.10 137.68 215.13
Year Ending Dec-18 312.30 308.62 279.01 273.13 346.12
Earnings (per share)
Quarter Ending Dec-17 -0.32 -0.32 -0.65 -0.67 -0.28
Quarter Ending Mar-18 -0.27 -0.29 -0.47 -0.39 --
Year Ending Dec-17 -0.73 -0.70 -1.16 -1.23 -1.46
Year Ending Dec-18 -0.57 -0.62 -1.61 -1.76 -0.29

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 13 1
Quarter Ending Mar-18 0 0 5 1
Year Ending Dec-17 0 0 15 1
Year Ending Dec-18 0 0 14 1
Earnings
Quarter Ending Dec-17 0 0 12 1
Quarter Ending Mar-18 0 0 6 1
Year Ending Dec-17 0 0 11 1
Year Ending Dec-18 0 0 13 1